May 11 (Reuters) - InMed Pharmaceuticals Inc:
* INMED REPORTS THIRD QUARTER FISCAL 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* Q3 LOSS PER SHARE C$0.01
* INMED PHARMACEUTICALS - AT MARCH 31, 2018, CO’S CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WERE $13.88 MILLION, VERSUS $6.71 MILLION AT JUNE 30, 2017 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.